PND32 - COST COMPARISON OF MULTIPLE SCLEROSIS FIRST LINE TREATMENT WITH AVAILABLE INTERFERONS WITHIN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1999
https://www.valueinhealthjournal.com/article/S1098-3015(18)35301-4/fulltext
Title :
PND32 - COST COMPARISON OF MULTIPLE SCLEROSIS FIRST LINE TREATMENT WITH AVAILABLE INTERFERONS WITHIN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35301-4&doi=10.1016/j.jval.2018.09.1999
First page :
Section Title :
Open access? :
No
Section Order :
1352